Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Defibrotide for Prevention of aGvHD
NCT03339297Phase 2Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Feb 2018
- Primary completion
- May 2020
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), Recombinant Proteins and Enzymes
- Countries
- 14
01
Overview
A Phase 2 trial of defibrotide in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Jazz Pharmaceuticals plc. Started Feb 2018; status: completed.
02
Drugs
defibrotide
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT03339297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03339297.